BNET Industries
Last Fiscal Year Sales:$1.6B
- Private
- US
Dow Jones Description
These are such busy times, with so much going on every day, that it can be pretty tough to remember what happened even a week or two ago - let alone last year. But sometimes you do want to remember those things! What was that good Italian restaurant you went to last month? Did you call your friend on her birthday three weeks ago? Can you find the digital pictures you took on July 4th? P.Bio answers these questions for you by automatically logging key events for each day, such as who you talked to, where you bought things, and the digital pictures you took. With P.Bio you'd simply jump to the day you went out for dinner with your friend and you were at the Mona Lisa restaurant. You can go to that day your friend had her birthday (or browse the week if you're not sure of the exact day) and you'd see the call you made. Enter "7/4/2007" into your P.Bio and you'll see the pictures you took - just like that! If you like to write a diary or keep a journal, P.Bio is the perfect tool for you because knowing a single fact about a day from a week or a month ago will usually be enough to help you remember most of what happened that day. P.Bio provides those facts for you automatically. P.Bio is also a great tool for recording many other kinds of events in your life, such as dinner recipes, kids progress in school, the clothes you wore each day, and nearly anything else. ...
Chairman and Chief Executive Officer
Tony L. WhiteNumber of Employees 2,000
Contact Information
850 Lincoln Centre Dr
Foster City, California 94404-1128
(650) 570-6667
Peer Companies
NAICS Code All Other Basic Organic Chemical Manufacturing: 325199
News & Analysis
Filter by
applied biosystems group - All News and Analysis
Applied Biosystems Group and Celera Group Third Quarter Fiscal 2008 Financial Results and Conference Call Scheduled for April 24, 2008
NORWALK, Conn. -- Applera Corporation announced today that it will issue fiscal 2008 third quarter financial results for its Applied Biosystems Group (NYSE:ABI) and Celera Group (NYSE:CRA) on Thursday, April 24, 2008. Results are scheduled for release before the opening of trading on the New York Stock Exchange. Tony...
Applied Biosystems Group and Celera Group Second Quarter Fiscal 2008 Financial Results and Conference Call Scheduled for January 24, 2008
NORWALK, Conn. -- Applera Corporation announced today that it will issue fiscal 2008 second quarter financial results for its Applied Biosystems Group (NYSE:ABI) and Celera Group (NYSE:CRA) on Thursday, January 24, 2008. Results are scheduled for release before the opening of trading on the New York Stock Exchange. Tony...
Research and Markets: The Applied Biosystems Group Deals and Alliances Profile Provides All the Crucial Company Information Required for Business and Competitor Intelligence Needs
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c76886) has announced the addition of Applied Biosystems Group Deals and Alliances Profile to their offering. - This profile is an essential source for company data and information. The profile examines Applied Biosystems Group's key business structure and operations, history and products, and...
Scientists in Spain Develop a Panel of Genetic Markers for Tracing Meat from Farm to Fork
Researchers Collaborate with Applied Biosystems to Validate Specific Genetic Polymorphisms for Identifying Individual Pigs from Commercial Breeds BARCELONA, Spain & FOSTER CITY, Calif. -- Scientists at the Universitat Autonoma de Barcelona, Spain, have developed and validated an identity test that can be used to confirm the breed and origin...
Celera and Ipsen Enter Research Collaboration to Develop Pharmacogenomic Tests
PARIS & ALAMEDA, Calif. -- Celera (NYSE:CRA), an Applera Corporation business, and Ipsen (Euronext:FR0010259150;IPN) today announced that they have entered into a research collaboration to develop biomarker and pharmacogenomic tests for growth failure patients. The initial phase of the collaboration will focus on the discovery and characterization of genetic markers...
Applied Biosystems Enters New Era of Life-Science Research With Launch of Next-Generation DNA Sequencing Platform
SOLiD[TM] System is Expected to Set New Standards for Genetic Analysis SAN DIEGO -- Applied Biosystems (NYSE:ABI), an Applera Corporation business, today entered a new era of life-science research by announcing the worldwide commercial availability of the SOLiD[TM] System, the company's highly anticipated next-generation DNA sequencing platform. The SOLiD...
DNA Analysis - Past, Present, and Future: Applied Biosystems Marks Next Phase of Genetic Discovery
FOSTER CITY, Calif. -- When the molecular structure of DNA was discovered more than 50 years ago, few could have imagined the ultimate impact of this discovery on life sciences. With the completion of the international Human Genome Project and other large-scale DNA sequencing efforts, scientists today have a wealth...
Celera Completes Acquisition of Atria Genetics, Inc
ALAMEDA, Calif. -- Celera (NYSE:CRA), an Applera Corporation business, today announced it has completed the acquisition of substantially all of the assets of Atria Genetics, Inc. for approximately $33 million in cash. South San Francisco-based Atria has a line of human leukocyte antigen HLA testing products that are used for...
Applied Biosystems to Webcast Investor Q&A on SOLiD™ Next-Generation DNA Sequencing System During the American Society of Human Genetics Annual Meeting
FOSTER CITY, Calif. -- Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, will webcast a meeting with investors on Thursday, October 25, 2007. The one-hour question and answer session, which will be held during the American Society of Human Genetics ASHG annual meeting in San Diego, is scheduled to begin...
Applied Biosystems Group and Celera Group First Quarter Fiscal 2008 Financial Results and Conference Call Scheduled for October 24, 2007
NORWALK, Conn. -- Applera Corporation announced today that it will issue fiscal 2008 first quarter financial results for its Applied Biosystems Group (NYSE:ABI) and Celera Group (NYSE:CRA) on Wednesday, October 24, 2007. Results are scheduled for release before the opening of trading on the New York Stock Exchange. Tony...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Kathy P. Ordonez | President |
| Mark O'Donnell | Division President, Global Services and Supply Chain |
| Paul S Johnson | President, Americas |
| Dennis L. Winger | Senior Vice President and Chief Financial Officer, Applera Corporation |
| Barbara J. Kerr | Senior Vice President, Human Resources |
| William B. Sawch | Senior Vice President and General Counsel, Applera Corporation |
| Claude Crawford | Vice President of Applied Biosystems' Research and Development |
| Jim Merryweather | Vice President, Strategic Planning and Business Development |
| Kim Caple | Vice President and General Manager |
| Michael G Schneider | Vice President, Worldwide Service |
| Paul D Grossman | Vice President, Intellectual Property |
| Robert Barrett | Vice President |
| Ugo D Deblasi | Vice President |
| John Bainbridge | General Manager for the Lims Business |
| Charles Purtell | Senior Director for Applied Biosystems' Consumables Business |
| Joseph Anacleto | Senior Director of Applied Biosystems' Food and Environmental Testing Group |
| Kevin McKernan | Senior Director of Scientific Operations |
| Nathan R Treff | Director of Molecular Biology, Reproductive Medicine Associates of New Jersey |
| Tamara Bond | Senior Director of Applied Biosystems' Pharmaceutical Business |
| William Craumer | Director, Investor Relations |
| Lydia Nuwaysir | Senior Product Manager |
| Mario Alberto Posada | Business Development Manager, Hispanic South America |
| Richard Fekete | Manager, Scientists, Sample Preparation R&D |
| Roger Canales | Senior Manager of Applied Biosystems' Solid Software Development Community |
| Dennis A. Gilbert | |
| Janet Ziegle | Senior Staff Scientist |
| Joel R Jung | |
| Toshihide Nishimura | |
| Norman Fogelsong | Venture Investor |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Tony L. White | Chairman and Chief Executive Officer |
| James R. Tobin | Co-Chair |
| Robert H. Hayes | Co-Chair |
| Arnold J. Levine | Board of Directors |
| Carolyn W Slayman | Board of Directors |
| Elaine Mardis | Board of Directors |
| George F Adam Jr | Board of Directors |
| Jean Luc Belingard | Board of Directors |
| Jean-Luc Belingard | Board of Directors |
| Laura Lauman | board member |
| Orin R Smith | Board of Directors |
| Philip Caldwell | Board of Directors |
| Richard H. Ayers | Board of Directors |
| Theodore E. Martin | Board of Directors |
| William H. Longfield | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Chairman and Chief Executive Officer | Current |
| Applera Corporation | Chairman, President & CEO | Current |
| Celera Genomics | Chairman, President and Chief Executive Officer | Current |
| Celera Diagnostics, LLC | Current | |
| Centenary College | Board of Directors | Current |
| Ingersoll-Rand Company Limited | Director | Current |
| C.R. Bard, Inc. | Board of Directors | Current |
| Productivity Inc. | Director | Current |
| PerkinElmer, Inc. | Chief Executive Officer | Former |
| C.R. Bard, Inc. | Chairman, President and Chief Executive Officer, Applera Corporation | Former |
| PerkinElmer, Inc. | President | Former |
| Baxter International Inc. | Executive Vice President | Former |
| AT&T Inc. | Director | Former |
| AT&T Inc. | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | President | Current |
| Celera Genomics Group | President | Current |
| Applera Corporation | Senior Vice President | Current |
| Celera Genomics | Senior Vice President, Applera and President, Celera Genomics and Celera Diagnostics | Current |
| Celera Genomics | CEO and Director | Current |
| Roche Molecular Systems, Inc. | Chief Executive Officer | Former |
| Applera Corporation | Chief Executive Officer | Former |
| Celera Genomics | President | Former |
| Applera Corporation | President | Former |
| Hoffmann-La Roche Inc. | President | Former |
| Roche Molecular Systems, Inc. | President | Former |
| Celera Genomics | President | Former |
| Celera Diagnostics, LLC | President | Former |
| Applied Biosystems Group | Senior Vice President, Applera Corporation, President, Celera Genomics and Celera Diagnostics | Former |
| Union Carbide Corporation | Former | |
| Roche | Former | |
| Applera Corporation | Chairman | Former |
| Hartwick College | Bachelor's Degree In Chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Division President, Global Services and Supply Chain | Current |
| Biolayer Corporation Limited | Senior Vice President, Global Operations and Services | Current |
| University Corp. | M.B.A. | Former |
| University of New Haven | Master's In Business Administration | Former |
| University of Connecticut | Bachelor's Degree In Liberal Arts | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | President, Americas | Current |
| Applied Biosystems Group | Vice President, Americas Sales | Current |
| Global Marketing Inc. | Vice President, Americas Sales | Former |
| Worcester Polytechnic Institute | Bachelor of Science In Mechanical Engineering | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Vice President and Chief Financial Officer, Applera Corporation | Current |
| Applera Corporation | Chief Financial Officer | Current |
| PerSeptive BioSystems, Inc. | CFO & Senior Vice President | Current |
| Applera Corporation | Senior Vice President | Current |
| Celera Genomics | Current | |
| Celera Diagnostics, LLC | Current | |
| Cephalon, Inc. | Board of Directors | Current |
| Cell Genesys, Inc. | Director | Current |
| Eisenhower Fellowships | Board of Directors | Current |
| Personalized Medicine Coalition | Board of Directors | Current |
| Personalized Medicine Coalition | Member | Current |
| The Cooper Companies, Inc. | Chief Financial Officer | Former |
| Chiron | Chief Financial Officer | Former |
| Chiron | Senior Vice President, Finance and Administration | Former |
| The Cooper Companies, Inc. | NA | Former |
| Chiron | Finance | Former |
| A.P. Pharma, Inc. | Board of Directors | Former |
| Columbia University | MBA In Finance | Former |
| Columbia University | Bachelor's Degree In History | Former |
| Siena College | Bachelor’S Degree In History | Former |
| Applera Corporation | Member | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Vice President, Human Resources | Current |
| Celera Genomics | Vice President, Human Resources | Current |
| PerSeptive BioSystems, Inc. | Vice President, HR | Current |
| Applera Corporation | Vice President, Human Resources | Current |
| Celera Diagnostics, LLC | Current | |
| Applera Corporation | Board of Directors | Current |
| Chiron | Vice President, Human Resources | Former |
| Applied Biosystems Group | Vice President, Human Resources, Applera Corporation | Former |
| Applied Biosystems Group | Human Resources Executive | Former |
| Golden Gate University | Master’S of Business Aministration | Former |
| University of Rochester | Master’S of Education | Former |
| Wittenberg University | Bachelor’S Degree In American Studies | Former |
| Applera Corporation | Member | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Vice President and General Counsel, Applera Corporation | Current |
| Applera Corporation | Senior Vice President | Current |
| Applera Corporation | General Counsel | Current |
| Celera Diagnostics, LLC | Current | |
| Celera Genomics | Current | |
| Accenture Ltd. | management consultant | Former |
| Cummings & Lockwood | Attorney | Former |
| Applied Biosystems Group | Corporate Attorney | Former |
| Georgetown University Law Center | JD | Former |
| Princeton University | Bachelor of Science degree in engineering | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Vice President of Applied Biosystems' Research and Development | Current |
| Rensselaer Polytechnic Institute | Bachelor of Chemical Engineering | Former |
| Organization | Position | Status |
|---|---|---|
| Incyte Corporation | Executive Vice President, Business Development & Commercial Operations | Current |
| Applied Biosystems Group | Vice President, Strategic Planning and Business Development | Current |
| Ciphergen Biosystems, Inc. | Executive Vice President, Pharmaceutical Corp Development | Former |
| Millennium Pharmaceuticals, Inc. | Vice President, Program Management | Former |
| Chiron | Director of Project Management | Former |
| Chiron | Senior Scientist | Former |
| The Corporate Development Company | Former | |
| Washington State University | PhD In Biochemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Vice President and General Manager | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Vice President, Worldwide Service | Current |
| Applied Biosystems Group | Division President, Service | Former |
| Advanced Micro Devices, Inc. | Former |
| Organization | Position | Status |
|---|---|---|
| Emiliem, Inc. | Senior Vice President, Strategy and Corporate Development | Current |
| Industry Ventures | Senior Vice President, Strategy and Corporate Development | Current |
| Bioreliance Corporation | Senior Vice President, Strategy and Corporate Development | Current |
| Microseq | Senior Vice President, Strategy and Corporate Development | Current |
| Biolayer Corporation Limited | Senior Vice President, Strategy and Corporate Development | Current |
| Pittsburgh Tissue Engineering Initiative, Inc | Senior Vice President, Strategy and Corporate Development | Current |
| Oligoperfect | Senior Vice President, Strategy and Corporate Development | Current |
| Olink | Senior Vice President, Strategy and Corporate Development | Current |
| IDEXX Laboratories, Inc. | Senior Vice President, Strategy and Corporate Development | Current |
| Seqanswers | Senior Vice President, Strategy and Corporate Development | Current |
| Ionsource, LLC | Senior Vice President, Strategy and Corporate Development | Current |
| Biosource International, Inc. | Senior Vice President, Strategy and Corporate Development | Current |
| Molecular Probes | Senior Vice President, Strategy and Corporate Development | Current |
| Resgen Inc. | Senior Vice President, Strategy and Corporate Development | Current |
| Applied Biosystems Group | Vice President, Intellectual Property | Current |
| Applied Biosystems Group | Research Associate | Former |
| Santa Clara University | JD | Former |
| University of California, Berkeley | Ph.D. in chemical engineering | Former |
| University of Virginia | master's degree in chemical engineering | Former |
| University of Virginia | B.S. | Former |
| University of California, Berkeley | B.S. | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | General Manager for the Lims Business | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Director for Applied Biosystems' Consumables Business | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Director of Applied Biosystems' Food and Environmental Testing Group | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Director of Scientific Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Director of Molecular Biology, Reproductive Medicine Associates of New Jersey | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Director of Applied Biosystems' Pharmaceutical Business | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Director, Investor Relations | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Product Manager | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Business Development Manager, Hispanic South America | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Manager, Scientists, Sample Preparation R&D | Current |
| Ambion Inc. | Research Scientist | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Manager of Applied Biosystems' Solid Software Development Community | Current |
Prior to founding VitaPath Genetics, Dennis A. Gilbert was Chief Scientific Officer and Vice President of Research of Applied Biosystems and a Vice President of Applera Corporation. He also directed the Applied Biosystems Advanced Research and Technology (ART) organization, which was responsible for identifying and developing new technologies. Previously, Dr. Gilbert had more than ten years of senior management experience at Applied Biosystems and Celera. Before being named Vice President of Advanced Research and Technology, he held the positions of Vice President, Genomics Applications, Applied Biosystems and Vice President, Gene Discovery, Celera. Prior to joining Applied Biosystems as a research scientist, he was Program Manager, Genetics at W.R. Grace. Dr. Gilbert received a bachelor of science in biochemistry and cell biology from the University of California, San Diego, and his Ph.D. in genetics from Johns Hopkins University, followed by postdoctoral training in population genetics at the National Cancer Institute.
| Organization | Position | Status |
|---|---|---|
| Vitapath Genetics, Inc. | Chief Scientific Officer | Current |
| Vitapath Genetics, Inc. | Founder | Current |
| Applied Biosystems Group | Current | |
| Applera Corporation | Chief Scientific Officer | Former |
| Applera Corporation | Vice President | Former |
| W.R. Grace & Company | Program Manager | Former |
| Applera Corporation | Research Scientist | Former |
| The Johns Hopkins University | PH.D. In Genetics | Former |
| University of California, San Diego | Bachelor of Science In Biochemistry and Cell Biology | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Staff Scientist | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Current |
Mr. Tobin has served as President and Chief Executive Officer of Boston Scientific Corporation, a medical device manufacturer, since March 1999. Mr. Tobin previously served as President and Chief Executive Officer of Biogen, Inc., a biotechnology company, from 1997 to 1998 and President and Chief Operating Officer from 1994 to 1997. Prior to joining Biogen, he held various positions at Baxter International Inc., including President and Chief Operating Officer from 1992 to 1994. Mr. Tobin is also a director of Boston Scientific and Curis, Inc.
| Organization | Position | Status |
|---|---|---|
| Celera Genomics | Current | |
| Applied Biosystems Group | Co-Chair | Current |
| Applera Corporation | Board Member | Current |
| Curis, Inc. | Board of Directors | Current |
| Beth Israel Deaconess Medical Center | Board Member | Current |
| Biogen Idec, Inc. | Chief Executive Officer | Former |
| Biogen, Inc. | Chief Executive Officer | Former |
| Boston Scientific Corporation | President & Chief Executive Officer | Former |
| Biogen Idec, Inc. | President | Former |
| Biogen, Inc. | President | Former |
| Baxter International Inc. | President | Former |
| Curis, Inc. | President | Former |
| Biogen Idec, Inc. | Chief Operating Officer | Former |
| Baxter International Inc. | Chief Operating Officer | Former |
| Biogen, Inc. | Chief Operating Officer | Former |
| Baxter International Inc. | Executive Vice President | Former |
| Baxter International Inc. | Managing Director | Former |
| Guidant Corporation | Director, President & CEO | Former |
| U.S. Navy | Lieutenant | Former |
| Baxter International Inc. | NA | Former |
| Curis, Inc. | Chair | Former |
| Creative BioMolecules, Inc. | Board of Directors | Former |
| Boston Scientific Corporation | Board of Directors | Former |
| Biogen, Inc. | Director | Former |
| Applied Biosystems Group | Board of Directors | Former |
| Harvard Business School | M.B.A | Former |
| Harvard College | A.B | Former |
| Organization | Position | Status |
|---|---|---|
| Harvard Business School | Professor of Business Administration | Current |
| Celera Genomics | Current | |
| Celera Diagnostics, LLC | Current | |
| Applied Biosystems Group | Co-Chair | Current |
| Applera Corporation | Director | Current |
| Helix Technology Corporation | Director | Current |
| Applied Biosystems Group | Committee Member | Current |
| Harvard Business School | Director | Former |
| Harvard Business School | Business Administration | Former |
Arnold J. Levine, Ph.D., is a Professor at The Cancer Institute of New Jersey, Robert Wood Johnson School of Medicine and a Professor at the Institute for Advanced Study. From 1998 - 2002, Dr. Levine was President of Rockefeller University. Prior to joining Rockefeller University, Dr. Levine was the Harry C. Weiss Professor in the Life Sciences and Chairman of the Department of Molecular Biology at Princeton University from 1984 - 1996. Dr. Levine also serves as a Director of Theravance, Inc. and Applera Corporation, publicly traded life science companies. Dr. Levine received a B.A. in Biology from Harpur College, State University of New York at Binghamton and a Ph.D. in Microbiology from the University of Pennsylvania.
| Organization | Position | Status |
|---|---|---|
| Infinity Pharmaceuticals, Inc | Lead Research & Development Director | Current |
| Cancer Institute | Prof | Current |
| Institute for Advanced Studies | Visiting Professor | Current |
| The Cancer Institute of New Jersey | Professor | Current |
| Celera Diagnostics, LLC | Current | |
| Celera Genomics | Current | |
| Bg Medicine, Inc. | Co-Chairman | Current |
| Theravance, Inc. | Chairperson | Current |
| Applied Biosystems Group | Board of Directors | Current |
| Exsar Corporation | Board of Directors | Current |
| National Academy of Sciences | Board of Directors | Current |
| Avidimer Therapeutics, Inc. | Board of Directors | Current |
| Theravance, Inc. | Board of Directors | Current |
| The Ellison Medical Foundation | Board of Directors | Current |
| Functional Genetics, Inc. | Board of Directors | Current |
| Infinity Pharmaceuticals, Inc | Board of Directors | Current |
| Applera Corporation | Director | Current |
| Theravance, Inc. | Committee Member | Current |
| The Rockefeller University | Chief Executive Officer | Former |
| The Rockefeller University | President | Former |
| Princeton University | Professor | Former |
| The Rockefeller University | Visiting Professor | Former |
| Princeton University | Chairman | Former |
| University of Pennsylvania | Ph.D. In Microbiology | Former |
| University of Pennsylvania School of Medicine | PhD In Microbiology | Former |
| State University of New York at Binghamton | B.A. | Former |
| National Academy of Sciences | member | Former |
| United States Public Health Services (USPHS) | Fellow | Former |
Dr. Slayman is the Sterling Professor of Genetics and Deputy Dean for Academic and Scientific Affairs at Yale University School of Medicine. She joined the Yale faculty in 1967. Dr. Slayman is a consultant to the National Institutes of Health, most recently having served as a member of the National Advisory General Medical Sciences Council, and a member of the Board of Overseers of Dartmouth Medical School.
| Organization | Position | Status |
|---|---|---|
| Genetics, Inc. | Sterling Professor | Current |
| Yale University School of Medicine | Deputy Dean | Current |
| National Institutes of Health | Consultant | Current |
| Celera Diagnostics, LLC | Current | |
| Celera Genomics | Current | |
| Applied Biosystems Group | Board of Directors | Current |
| Applera Corporation | Director | Current |
| Progress Daily | Committee Member | Current |
| Flandersbio | Committee Member | Current |
| Olink | Committee Member | Current |
| Applied Biosystems Group | Committee Member | Current |
| Yale University | Deputy Dean for Academic and Scientific Affairs | Former |
| Dartmouth Medical School | member | Former |
| Organization | Position | Status |
|---|---|---|
| Washington University School of Medicine | Assistant Professor of Genetics | Current |
| Progress Daily | Board of Directors | Current |
| Flandersbio | Board of Directors | Current |
| Applied Biosystems Group | Board of Directors | Current |
| Orion Genomics, LLC | Board of Directors | Current |
| The University of Oklahoma | Ph.D. In Chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Board of Directors | Current |
| Applied Biosystems Group | Committee Member | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | board member | Current |
| Applied Biosystems Group | Division President, Proteomics and Small Molecule Division | Former |
| Applied Biosystems Group | Product Manager | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Board of Directors | Current |
Mr. Ayers is the retired Chairman and Chief Executive Officer of The Stanley Works, a tool and hardware manufacturer. He was an advisor to the Chairman and Chief Executive Officer of Stanley from January 1997 to October 1997 after having served as Chairman and Chief Executive Officer of Stanley from May 1989 to December 1996. Mr. Ayers is a Trustee of MassMutual Institutional Funds and MML Series Investment Fund and a director of Instron Corporation.
| Organization | Position | Status |
|---|---|---|
| Applera Corporation | Committee Member | Current |
| Celera Diagnostics, LLC | Current | |
| The Stanley Works | Chairman | Current |
| Instron Corporation | Director | Current |
| Applera Corporation | Director | Current |
| Celera Genomics | Board of Directors | Current |
| Applied Biosystems Group | Board of Directors | Current |
| Applied Biosystems Group | Committee Member | Current |
| Olink | Committee Member | Current |
| The Stanley Works | Chief Executive Officer | Former |
| Organization | Position | Status |
|---|---|---|
| Barnes Group Inc. | Chief Executive Officer | Current |
| Barnes Group Inc. | President | Current |
| Barnes Group Inc. | Group Vice President | Current |
| Celera Diagnostics, LLC | Current | |
| Celera Genomics | Current | |
| Ingersoll-Rand Company Limited | Board of Directors | Current |
| C.R. Bard, Inc. | Board of Directors | Current |
| Applied Biosystems Group | Board of Directors | Current |
| Applera Corporation | Board of Directors | Current |
| Barnes Group Inc. | Director | Former |
Array
| Organization | Position | Status |
|---|---|---|
| NYSE Group, Inc. | Current | |
| Celera Diagnostics, LLC | Current | |
| Celera Genomics | Current | |
| Rozynski & Associates | Current | |
| Resgen Inc. | Board of Directors | Current |
| Pittsburgh Tissue Engineering Initiative, Inc | Board of Directors | Current |
| Olink | Board of Directors | Current |
| Ionsource, LLC | Board of Directors | Current |
| IDEXX Laboratories, Inc. | Board of Directors | Current |
| Industry Ventures | Board of Directors | Current |
| HCR ManorCare, Inc. | Board of Directors | Current |
| Applied Biosystems Group | Board of Directors | Current |
| Horizon Health Corporation | Director | Current |
| West Pharmaceutical Services, Inc. | Director | Current |
| Applera Corporation | Director | Current |
| C.R. Bard, Inc. | Director | Current |
| Microseq | Board of Directors | Current |
| Biolayer Corporation Limited | Board of Directors | Current |
| Centenary College | Trustee | Current |
| Healthios Group, LLC | Member | Current |
| C.R. Bard, Inc. | President | Former |
| Lifemark | Officer | Former |
| American Hospital Supply Corporation | Former | |
| Lifemark | Director | Former |
| Northwestern University | Graduate Degree In Management | Former |
| Drake University | Bachelor's Degrees In Business Administration | Former |
| Organization | Position | Status |
|---|---|---|
| International Venture Partners, Inc. | General Partner | Current |
| Cortina Systems Corporation | Board of Directors | Current |
| Genentech, Inc. | Venture Investor | Current |
| Verisity, Ltd. | Venture Investor | Current |
| Aspect Software, Inc. | Investor | Current |
| 3Com Corporation | Venture Investor | Current |
| Cypress Semiconductor Corporation | Venture Investor | Current |
| Silicon Graphics, Inc. | Venture Investor | Current |
| Artisan Components, Inc. | Investor | Current |
| WebEx Communications, Inc. | Venture Investor | Current |
| MIPS Technologies, Inc. | Venture Investor | Current |
| LSI Corporation | Venture Investor | Current |
| Applied Biosystems Group | Venture Investor | Current |
| Dust Networks | Venture Investor | Current |
| Linear Technology Corp. | Venture Investor | Current |
| SupportSoft, Inc. | Venture Investor | Current |
| Concur Technologies, Inc. | Investor | Current |
| Compaq Computers | Investor | Current |
| Websense Inc. | Investor | Current |
| Lam Research Corporation | Investor | Current |
| Polycom, Inc. | Investor | Current |
| Motion Computing, Inc. | Investor | Current |
| @Road, Inc. | Venture Investor | Current |
| Amgen Inc. | Venture Investor | Current |
| Quantum Corporation | Venture Investor | Current |
| Digital River, Inc. | Venture Investor | Current |
| Institutional Venture Partners | General Partner | Former |
| Hewlett-Packard Company | computer programmer | Former |
| McKinsey & Company, Inc. | management consultant | Former |
| Stanford University | Board Member | Former |
| Harvard Law School | J.D | Former |
| Harvard Business School | M.B.A | Former |
| Stanford University | B.S. degree in Management Science & Engineering | Former |
Executive News
-
Strategic Product Development Expert to Educate Utah Technology Company Executives
-
UPDATE 1-Leerink Swann raises Boston Scientific to outperform
Industry Transcripts by Seeking Alpha
-
Donaldson Company Inc. F1Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 19, 2009about DCI
-
La-Z-Boy Inc. F2Q10 (Qtr End 10/24/09) Earnings Call Transcript
on Nov 18, 2009about LZB
-
KongZhong Q3 2009 Earnings Call Transcript
on Nov 11, 2009about KONG
-
Harbin Electric, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about HRBN
-
Capstone Turbine Corporation F2Q10 (Qtr End 09/30/09) Earnings Call Transcript
on Nov 09, 2009about CPST

